Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
The evolution of transdermal therapy for overactive bladder.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The evolution of transdermal therapy for overactive bladder.
The evolution of transdermal therapy for overactive bladder. Curr Urol Rep. 2009 Sep; 10(5):338-41.
View in:
PubMed
subject areas
Administration, Cutaneous
Gels
Humans
Mandelic Acids
Muscarinic Antagonists
Urinary Bladder, Overactive
authors with profiles
Peter Sand